Applications are open! Become a 2025-26 Stanford Biodesign Innovation Fellow. Application link 👇🏾 #innovationeducation #healthtech
Stanford Byers Center for Biodesign
Higher Education
Stanford, California 14,463 followers
Educating the next generation of health technology innovators
About us
We are dedicated to advancing health outcomes and equity through innovation education, translation and policy. WELCOME TO THE FUTURE OF HEALTHCARE At Stanford Biodesign, we bring the world’s most promising minds into our circle to investigate, inspire, and innovate a healthier world for all. We offer a portfolio of educational programs to engage both aspiring and experienced innovators in the important challenge of reinventing health care with the help of technology. Each of our programs teaches our need-driven, value-based approach to health technology innovation and how to apply it to improve lives everywhere.
- Website
-
https://biodesign.stanford.edu/
External link for Stanford Byers Center for Biodesign
- Industry
- Higher Education
- Company size
- 11-50 employees
- Headquarters
- Stanford, California
- Type
- Educational
- Founded
- 2001
- Specialties
- Fellowships, Stanford Undergraduate Classes, Executive Education, Grants, Medicine, Biodesign, Technology, Medical Devices, Healthcare, Life Sciences, Policy, Global Education, Innovation, Design, Bioengineering, Stanford Medicine, equity, translation, diversity, and inclusion
Locations
-
Primary
318 Campus Dr E
Stanford, California 94305, US
Employees at Stanford Byers Center for Biodesign
Updates
-
Back in 2007 when we launched Stanford India Biodesign (SIB), our first global collaboration, together with the All India Institute of Medical Sciences (AIIMS) and the Indian Institute of Technology (IIT) Delhi, we could not have imagined how much we would learn from the program, the remarkable impact it would have in India, and how it would influence our subsequent partnerships in other countries. 🇮🇳 Our dear friend Prof. MK Bhan, a true visionary who was then Secretary of Biotechnology, Government of India, was instrumental in creating this first-of-its-kind partnership. Founding team members, Drs. Balram Bhargava, Anurag Mairal, PhD, and Rajiv Doshi, MD reconnected this past weekend together with Stanford Biodesign’s director emeritus Paul Yock! SIB transitioned to independent status as the School of International Biodesign after nine years. Anurag and Rajiv continue to lead other Stanford Biodesign India programs including the Founder’s Forum, an executive education program for India’s top healthtech start-up innovators (the most recent session was hosted in Bangalore earlier this month), and an Edwards Lifesciences Foundation-funded initiative to combat rheumatic heart disease. Dr. Bhargava would later serve as director general of the Indian Council of Medical Research and continues to advise large and small health technology and pharma companies in India. The ecosystem created by these India Biodesign programs continues to impact hundreds of millions of patients in India and beyond! #TBT #historylesson #reunion #globalbiodesign #healthtech #medtech
-
💊“We hope our solution will greatly increase screening versus colonoscopy, so that deadly colorectal cancer can be detected in its earliest stages and lives can be saved.” As part of their Bioengineering Senior Capstone Design course, Kelly Lopez-Cid, Shreya Garg, and Gabe Eduardo Seir focused on finding a way to increase screening compliance for colorectal cancer, the second leading cause of cancer death in the US among cancers that affect both men and women. The ColoTech team’s concept is a less invasive solution: a pill to detect early-stage cancer through the emission of fluorescence signals. Read more about their project: https://lnkd.in/eq4HGATn
-
Stanford Biodesign director emeritus Paul Yock, MD and biotechnology director, D. Michael Ackermann, were among the speakers at last week’s Ophthalmic Innovation Symposium hosted by the Byers Eye Institute at Stanford. Centered on the theme, "From Concept to Clinic”, they shared their expert perspectives on innovation and how to effectively translate an idea into patient care. 💡Fun fact: Michael, a 2010-11 alumnus of the Innovation Fellowship, has founded multiple companies in the ophthalmology space—his very first, Occuleve, acquired by Allergan, was based on his fellowship project. #innovationeducation #healthtech #ophthalmology
-
Many thanks to our alumni fellows Nathaniel G. George, Anastasia Ntracha, Ignacio Pérez, Marta Arenas-Jal, PhD, and Cyan Brown, MD, MPH for their time and amazing insights! Here are some highlights from the discussion 👇 The recording will be available on our website next week: https://lnkd.in/gyAyPJTv If you have any questions regarding the application process, please contact our Fellowships Manager, Meghan Stawitcke (meghans4@stanford.edu). #biodesign #fellowship #innovation
-
🟢LIVE NOW! Join five of our Innovation Fellowship alumni as they discuss their experiences in the fellowship as international trainees: what worked well, what they learned, and what surprised them along the way. Update: The webinar recording will be available next week on our website: biodesign.stanford.edu
-
🎙️Oliver Aalami, MD, Stanford Biodesign’s director of digital health; Paul Schmiedmayer, assistant director of digital health; and Vishnu Ravi, MD, lead architect for digital health, joined Yosra M. today for a conversation about impactful innovation education, as part of an episode of Nature Portfolio’s Digital Medicine podcast series. They shared insights from their experience teaching computer science and medical students to design, build, and implement real-world digital health solutions by applying the biodesign innovation process and using the Stanford Spezi open-source ecosystem. They highlighted the importance of fostering multidisciplinary collaboration and effective communication between fields to create projects that can solve real health needs. Thank you so much Yosra for hosting this session! You can listen to the complete conversation here: https://lnkd.in/ef4S7PzM Follow the Stanford Biodesign Digital Health page to keep up with the latest developments from the team! #innovationeducation #healthtech #digitalhealth
-
“If we’re able to help even 10 immigrants begin a better life because of our solution, then we’ve made an impact.” Health innovation goes beyond developing medical devices: it’s also about addressing social factors impacting the mental health and overall well-being of diverse groups. During their Biodesign for Societal Health course, Layth Alkhani, Ethan Bell, and Sydney Covitz zeroed in on the stress immigrants experience in their lives and how the uncertain process of completing immigration documentation negatively impacts their mental health. Their project “GreenScreen” aims to ease this burden with an AI-powered system that streamlines the immigration paperwork, reducing stress, errors, and cost for individuals and employers. Read more about their vision: https://lnkd.in/eCQW-kgR
GreenScreen: Improving Immigrant Mental Health with a Streamlined Solution
biodesign.stanford.edu
-
"I love the capacity to intervene in a situation that could be or is grievous and turn it into something that is extraordinarily positive." Here’s your opportunity to listen again to the inspiring conversation between Ted W. Love, MD and Uday Kumar at our Innovator’s Workbench event earlier this year. Ted shared some of the pivotal decisions, opportunities, and challenges that shaped his remarkable career as a cardiologist, biotechnology executive, and chair of the board of the Biotechnology Innovation Organization. Watch now: https://lnkd.in/eQcq52ry
From the Innovator's Workbench with Ted W. Love, MD
https://www.youtube.com/
-
🫀🩺“We were able to observe some of these babies in the NICU. It's heartbreaking.… We all felt that a better solution could make a huge difference in enabling more informed care decisions and better patient outcomes”. Pedro Ambriz Jr., Zofia Dudek, Dylan MacFarlane, Amin Sajjadian, and Khanh Tran first learned about the need to better measure and monitor the Qp/Qs ratio, or blood oxygenation, in babies with hypoplastic left heart syndrome (HLHS) during their Bioengineering Senior Capstone Design class. In babies with this rare congenital heart defect, the left side of the heart is underdeveloped and multiple surgeries are required to treat the condition soon after birth. The Circadium team developed a concept for a wireless implant to measure the blood flow more accurately without the use of anesthesia or invasive catheterization. Read more about the challenges of developing this solution: https://lnkd.in/enEx4a-P
Circardium: Improving the Lives of Newborns with Hypoplastic Left Heart Syndrome
biodesign.stanford.edu